Global Tinea Corporis Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4916416
- 88 Pages
- March 2022
- Medical Devices
The United States Tinea Corporis Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tinea Corporis Drugs market, reaching US$ million by the year 2028. As for the Europe Tinea Corporis Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Tinea Corporis Drugs players cover Sun Pharmaceutical, Teva, Glenmark, and Aurobindo, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Tinea Corporis Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Antifungals
Steroids
Anti-Infective Combinations
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sun Pharmaceutical
Teva
Glenmark
Aurobindo
AvKare
Novartis
Sebela
Bayer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tinea Corporis Drugs Market Size 2017-2028
2.1.2 Tinea Corporis Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Tinea Corporis Drugs Segment by Type
2.2.1 Antifungals
2.2.2 Steroids
2.2.3 Anti-Infective Combinations
2.3 Tinea Corporis Drugs Market Size by Type
2.3.1 Tinea Corporis Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Tinea Corporis Drugs Market Size Market Share by Type (2017-2022)
2.4 Tinea Corporis Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Tinea Corporis Drugs Market Size by Application
2.5.1 Tinea Corporis Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Tinea Corporis Drugs Market Size Market Share by Application (2017-2022)
3 Tinea Corporis Drugs Market Size by Player
3.1 Tinea Corporis Drugs Market Size Market Share by Players
3.1.1 Global Tinea Corporis Drugs Revenue by Players (2020-2022)
3.1.2 Global Tinea Corporis Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Tinea Corporis Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Tinea Corporis Drugs by Regions
4.1 Tinea Corporis Drugs Market Size by Regions (2017-2022)
4.2 Americas Tinea Corporis Drugs Market Size Growth (2017-2022)
4.3 APAC Tinea Corporis Drugs Market Size Growth (2017-2022)
4.4 Europe Tinea Corporis Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Tinea Corporis Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Tinea Corporis Drugs Market Size by Country (2017-2022)
5.2 Americas Tinea Corporis Drugs Market Size by Type (2017-2022)
5.3 Americas Tinea Corporis Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tinea Corporis Drugs Market Size by Region (2017-2022)
6.2 APAC Tinea Corporis Drugs Market Size by Type (2017-2022)
6.3 APAC Tinea Corporis Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Tinea Corporis Drugs by Country (2017-2022)
7.2 Europe Tinea Corporis Drugs Market Size by Type (2017-2022)
7.3 Europe Tinea Corporis Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tinea Corporis Drugs by Region (2017-2022)
8.2 Middle East & Africa Tinea Corporis Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Tinea Corporis Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Tinea Corporis Drugs Market Forecast
10.1 Global Tinea Corporis Drugs Forecast by Regions (2023-2028)
10.1.1 Global Tinea Corporis Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Tinea Corporis Drugs Forecast
10.1.3 APAC Tinea Corporis Drugs Forecast
10.1.4 Europe Tinea Corporis Drugs Forecast
10.1.5 Middle East & Africa Tinea Corporis Drugs Forecast
10.2 Americas Tinea Corporis Drugs Forecast by Country (2023-2028)
10.2.1 United States Tinea Corporis Drugs Market Forecast
10.2.2 Canada Tinea Corporis Drugs Market Forecast
10.2.3 Mexico Tinea Corporis Drugs Market Forecast
10.2.4 Brazil Tinea Corporis Drugs Market Forecast
10.3 APAC Tinea Corporis Drugs Forecast by Region (2023-2028)
10.3.1 China Tinea Corporis Drugs Market Forecast
10.3.2 Japan Tinea Corporis Drugs Market Forecast
10.3.3 Korea Tinea Corporis Drugs Market Forecast
10.3.4 Southeast Asia Tinea Corporis Drugs Market Forecast
10.3.5 India Tinea Corporis Drugs Market Forecast
10.3.6 Australia Tinea Corporis Drugs Market Forecast
10.4 Europe Tinea Corporis Drugs Forecast by Country (2023-2028)
10.4.1 Germany Tinea Corporis Drugs Market Forecast
10.4.2 France Tinea Corporis Drugs Market Forecast
10.4.3 UK Tinea Corporis Drugs Market Forecast
10.4.4 Italy Tinea Corporis Drugs Market Forecast
10.4.5 Russia Tinea Corporis Drugs Market Forecast
10.5 Middle East & Africa Tinea Corporis Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Tinea Corporis Drugs Market Forecast
10.5.2 South Africa Tinea Corporis Drugs Market Forecast
10.5.3 Israel Tinea Corporis Drugs Market Forecast
10.5.4 Turkey Tinea Corporis Drugs Market Forecast
10.5.5 GCC Countries Tinea Corporis Drugs Market Forecast
10.6 Global Tinea Corporis Drugs Forecast by Type (2023-2028)
10.7 Global Tinea Corporis Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sun Pharmaceutical
11.1.1 Sun Pharmaceutical Company Information
11.1.2 Sun Pharmaceutical Tinea Corporis Drugs Product Offered
11.1.3 Sun Pharmaceutical Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sun Pharmaceutical Main Business Overview
11.1.5 Sun Pharmaceutical Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Tinea Corporis Drugs Product Offered
11.2.3 Teva Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Glenmark
11.3.1 Glenmark Company Information
11.3.2 Glenmark Tinea Corporis Drugs Product Offered
11.3.3 Glenmark Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Glenmark Main Business Overview
11.3.5 Glenmark Latest Developments
11.4 Aurobindo
11.4.1 Aurobindo Company Information
11.4.2 Aurobindo Tinea Corporis Drugs Product Offered
11.4.3 Aurobindo Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Aurobindo Main Business Overview
11.4.5 Aurobindo Latest Developments
11.5 AvKare
11.5.1 AvKare Company Information
11.5.2 AvKare Tinea Corporis Drugs Product Offered
11.5.3 AvKare Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 AvKare Main Business Overview
11.5.5 AvKare Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Tinea Corporis Drugs Product Offered
11.6.3 Novartis Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Sebela
11.7.1 Sebela Company Information
11.7.2 Sebela Tinea Corporis Drugs Product Offered
11.7.3 Sebela Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sebela Main Business Overview
11.7.5 Sebela Latest Developments
11.8 Bayer
11.8.1 Bayer Company Information
11.8.2 Bayer Tinea Corporis Drugs Product Offered
11.8.3 Bayer Tinea Corporis Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Bayer Main Business Overview
11.8.5 Bayer Latest Developments
12 Research Findings and Conclusion
Table 1. Tinea Corporis Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Antifungals
Table 3. Major Players of Steroids
Table 4. Major Players of Anti-Infective Combinations
Table 5. Tinea Corporis Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Tinea Corporis Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Tinea Corporis Drugs Market Size Market Share by Type (2017-2022)
Table 8. Tinea Corporis Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Tinea Corporis Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Tinea Corporis Drugs Market Size Market Share by Application (2017-2022)
Table 11. Global Tinea Corporis Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Tinea Corporis Drugs Revenue Market Share by Player (2020-2022)
Table 13. Tinea Corporis Drugs Key Players Head office and Products Offered
Table 14. Tinea Corporis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Tinea Corporis Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Tinea Corporis Drugs Market Size Market Share by Regions (2017-2022)
Table 19. Americas Tinea Corporis Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Tinea Corporis Drugs Market Size Market Share by Country (2017-2022)
Table 21. Americas Tinea Corporis Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Tinea Corporis Drugs Market Size Market Share by Type (2017-2022)
Table 23. Americas Tinea Corporis Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Tinea Corporis Drugs Market Size Market Share by Application (2017-2022)
Table 25. APAC Tinea Corporis Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Tinea Corporis Drugs Market Size Market Share by Region (2017-2022)
Table 27. APAC Tinea Corporis Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Tinea Corporis Drugs Market Size Market Share by Type (2017-2022)
Table 29. APAC Tinea Corporis Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Tinea Corporis Drugs Market Size Market Share by Application (2017-2022)
Table 31. Europe Tinea Corporis Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Tinea Corporis Drugs Market Size Market Share by Country (2017-2022)
Table 33. Europe Tinea Corporis Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Tinea Corporis Drugs Market Size Market Share by Type (2017-2022)
Table 35. Europe Tinea Corporis Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Tinea Corporis Drugs Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Tinea Corporis Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Tinea Corporis Drugs Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Tinea Corporis Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Tinea Corporis Drugs Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Tinea Corporis Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Tinea Corporis Drugs Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Tinea Corporis Drugs
Table 44. Key Market Challenges & Risks of Tinea Corporis Drugs
Table 45. Key Industry Trends of Tinea Corporis Drugs
Table 46. Global Tinea Corporis Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Tinea Corporis Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Tinea Corporis Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Tinea Corporis Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Tinea Corporis Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Tinea Corporis Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 52. Sun Pharmaceutical Details, Company Type, Tinea Corporis Drugs Area Served and Its Competitors
Table 53. Sun Pharmaceutical Tinea Corporis Drugs Product Offered
Table 54. Sun Pharmaceutical Tinea Corporis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Sun Pharmaceutical Main Business
Table 56. Sun Pharmaceutical Latest Developments
Table 57. Teva Details, Company Type, Tinea Corporis Drugs Area Served and Its Competitors
Table 58. Teva Tinea Corporis Drugs Product Offered
Table 59. Teva Main Business
Table 60. Teva Tinea Corporis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Teva Latest Developments
Table 62. Glenmark Details, Company Type, Tinea Corporis Drugs Area Served and Its Competitors
Table 63. Glenmark Tinea Corporis Drugs Product Offered
Table 64. Glenmark Main Business
Table 65. Glenmark Tinea Corporis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Glenmark Latest Developments
Table 67. Aurobindo Details, Company Type, Tinea Corporis Drugs Area Served and Its Competitors
Table 68. Aurobindo Tinea Corporis Drugs Product Offered
Table 69. Aurobindo Main Business
Table 70. Aurobindo Tinea Corporis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Aurobindo Latest Developments
Table 72. AvKare Details, Company Type, Tinea Corporis Drugs Area Served and Its Competitors
Table 73. AvKare Tinea Corporis Drugs Product Offered
Table 74. AvKare Main Business
Table 75. AvKare Tinea Corporis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. AvKare Latest Developments
Table 77. Novartis Details, Company Type, Tinea Corporis Drugs Area Served and Its Competitors
Table 78. Novartis Tinea Corporis Drugs Product Offered
Table 79. Novartis Main Business
Table 80. Novartis Tinea Corporis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Novartis Latest Developments
Table 82. Sebela Details, Company Type, Tinea Corporis Drugs Area Served and Its Competitors
Table 83. Sebela Tinea Corporis Drugs Product Offered
Table 84. Sebela Main Business
Table 85. Sebela Tinea Corporis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Sebela Latest Developments
Table 87. Bayer Details, Company Type, Tinea Corporis Drugs Area Served and Its Competitors
Table 88. Bayer Tinea Corporis Drugs Product Offered
Table 89. Bayer Main Business
Table 90. Bayer Tinea Corporis Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Bayer Latest Developments
List of Figures
Figure 1. Tinea Corporis Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tinea Corporis Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Tinea Corporis Drugs Market Size Market Share by Type in 2021
Figure 7. Tinea Corporis Drugs in Hospital Pharmacies
Figure 8. Global Tinea Corporis Drugs Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Tinea Corporis Drugs in Retail Pharmacies
Figure 10. Global Tinea Corporis Drugs Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. Tinea Corporis Drugs in Online Pharmacies
Figure 12. Global Tinea Corporis Drugs Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 13. Global Tinea Corporis Drugs Market Size Market Share by Application in 2021
Figure 14. Global Tinea Corporis Drugs Revenue Market Share by Player in 2021
Figure 15. Global Tinea Corporis Drugs Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Tinea Corporis Drugs Market Size 2017-2022 ($ Millions)
Figure 17. APAC Tinea Corporis Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Europe Tinea Corporis Drugs Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Tinea Corporis Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Americas Tinea Corporis Drugs Value Market Share by Country in 2021
Figure 21. Americas Tinea Corporis Drugs Consumption Market Share by Type in 2021
Figure 22. Americas Tinea Corporis Drugs Market Size Market Share by Application in 2021
Figure 23. United States Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Tinea Corporis Drugs Market Size Market Share by Region in 2021
Figure 28. APAC Tinea Corporis Drugs Market Size Market Share by Application in 2021
Figure 29. China Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Tinea Corporis Drugs Market Size Market Share by Country in 2021
Figure 36. Europe Tinea Corporis Drugs Market Size Market Share by Type in 2021
Figure 37. Europe Tinea Corporis Drugs Market Size Market Share by Application in 2021
Figure 38. Germany Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Tinea Corporis Drugs Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Tinea Corporis Drugs Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Tinea Corporis Drugs Market Size Market Share by Application in 2021
Figure 46. Egypt Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Tinea Corporis Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 52. APAC Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 53. Europe Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 55. United States Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Canada Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 59. China Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Japan Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 61. Korea Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 63. India Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Australia Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 65. Germany Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 66. France Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 67. UK Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Italy Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Russia Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Spain Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Israel Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Tinea Corporis Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
